Ocular drug delivery – a look towards nanobioadhesives

Bibliography

• Robinson JC. Ocular anatomy and physiology relevant to ocular drug delivery. In: Mitra AK, editor, Ophthalmic drug delivery systems. Marcel Dekker, New York; 1993. p. 29-58
   Google Scholar
• Henderer JD, Rapuano C. Ocular pharmacology. Goodman and Gilman's Textbook of Pharmacology. McGraw-Hill, New York, 12th edition; 2004
   Google Scholar
• Li N, Zhuang C, Wang M, Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 2009;379(1):131-8
   PubMedGoogle Scholar
• Meisner D, Mezei M. Liposome ocular delivery systems. Adv Drug Deliv Rev 1995;16:75-93
   Web of Science ®Google Scholar
• Robinson JR, Mlynek GM. Bioadhesive and phase-change polymers for ocular drug delivery. Adv Drug Deliv Rev 1995;16:45-50
   Web of Science ®Google Scholar
• Nagarwal RC, Kant S, Singh PN, Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Control Release 2009;136:2-13
   PubMed Web of Science ®Google Scholar
• Bucolo C, Maltese A, Drago F. When nanotechnology meets the ocular surface. Expert Rev Ophthalmol 2008;3:325-32
   Google Scholar
• Raju HB, Goldberg JL. Nanotechnology for ocular therapeutics and tissue repair. Expert Rev Ophthalmol 2008;3:431-6
   Google Scholar
• de la Fuente M, Ravina M, Paolicelli P, Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv Drug Deliv Rev 2010;62:100-17
   PubMed Web of Science ®Google Scholar
• De Campos AM, Sanchez A, Alonso MJ. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm 2001;224:159-68
   PubMed Web of Science ®Google Scholar
• Bourges JL, Gautier SE, Delie F, Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest Ophthalmol Vis Sci 2003;44:3562-9
   PubMed Web of Science ®Google Scholar
• De Campos AM, Diebold Y, Carvalho EL, Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res 2004;21:803-10
   PubMed Web of Science ®Google Scholar
• Kayser O, Lemke A, Hernandez-Trejo N. The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechnol 2005;6:3-5
   PubMed Web of Science ®Google Scholar
• Sanchez A, Alonso MJ. Nanoparticular carriers for ocular drug delivery. In: Torchilin VP, editor, Nanoparticulates as drug carriers. London, Imperial College Press; 2006. p. 649-73
   Google Scholar
• Badawi AA, El-Laithy HM, El Qidra RK, Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharm Res 2008;31:1040-9
   PubMed Web of Science ®Google Scholar
• de la Fuente M, Csaba N, Garcia-Fuentes M, Alonso MJ. Nanoparticles as protein and gene carriers to mucosal surfaces. Nanomed 2008;3:845-57
   PubMed Web of Science ®Google Scholar
• Vandervoort J, Ludwig A. Preparation and evaluation of drug-loaded gelatine nanoparticles for topical ophthalmic use. Eur J Pharm Biopharm 2004;57:251-61
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Urban MC, Cinto PO, Colloidal carriers for ophthalmic drug delivery. Curr Drug Targets 2005;6:363-71
   PubMed Web of Science ®Google Scholar
• Hamidi M, Azadi A, Rafiei P. Hydrogel nanoparticles in drug delivery. Adv Drug Deliv Rev 2008;60:1638-49
   PubMed Web of Science ®Google Scholar
• Borras T. Recent developments in ocular gene therapy. Exp Eye Res 2003;76:643-52
   PubMed Web of Science ®Google Scholar
• Bloquel C, Bourges JL, Touchard E, Non-viral ocular gene therapy: potential ocular therapeutic avenues. Adv Drug Deliv Rev 2006;58:1224-42
   PubMed Web of Science ®Google Scholar
• Langer K, Mutschler E, Lambrecht G, Methylmethacrylate sulfopropylmethacrylate copolymer nanoparticles for drug delivery Part III: evaluation as drug delivery system for ophthalmic applications. Int J Pharm 1997;158:219-31
   Web of Science ®Google Scholar
• Losa C, Calvo P, Castro E, Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. J Pharm Pharmacol 1991;43:548-52
   PubMed Web of Science ®Google Scholar
• Losa C, Alonso MJ, Vila JL, Reduction of cardiovascular side effects associated with ocular administration of metipranolol by inclusion in polymeric nanocapsules. J Ocul Pharmacol 1992;8:191-8
   PubMedGoogle Scholar
• Losa C, Marchal-Heussler L, Orallo F, Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Pharm Res 1993;10:80-7
   PubMed Web of Science ®Google Scholar
• Calvo P, Alonso MJ, Vila-Jato JL, Robinson JR. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J Pharm Pharmacol 1996;48:1147-52
   PubMed Web of Science ®Google Scholar
• Calvo P, Sanchez A, Martinez J, Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A. Pharm Res 1996;13:311-15
   PubMed Web of Science ®Google Scholar
• Calvo P, Vila-Jato JL, Alonso MJ. Comparative in vitro evaluation of several colloidal systems, nanoparticles, nanocapsules, and nanoemulsions, as ocular drug carriers. J Pharm Sci 1996;85:530-6
   PubMed Web of Science ®Google Scholar
• Dillen K, Bridts C, Van der Veken P, Adhesion of PLGA or Eudragit®/PLGA nanoparticles to Staphylococcus and Pseudomona. Int J Pharm 2008;349(1-2):234-40
   PubMedGoogle Scholar
• Ludwig A. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 2005;57:1595-639
   PubMed Web of Science ®Google Scholar
• Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm 1997;153:41-50
   Web of Science ®Google Scholar
• De Campos AM, Sanchez A, Gref R, The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci 2003;20:73-81
   PubMed Web of Science ®Google Scholar
• Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int J Pharm 1992;78:43-8
   Web of Science ®Google Scholar
• Schipper NGM, Olsson S, Hoogstraate JA, Chitosans as absorption enhancers for poorly absorbable drugs 2: mechanism of absorption enhancement. Pharm Res 1997;14:923-9
   PubMed Web of Science ®Google Scholar
• Felt O, Furrer P, Mayer JM, Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm 1999;180:185-93
   PubMed Web of Science ®Google Scholar
• Alonso MJ, Sanchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol 2003;55:1451-63
   PubMed Web of Science ®Google Scholar
• Ding S. Recent developments in ophthalmic drug delivery. PSTT 1998;1(8):328-35
   Google Scholar
• Zimmer A, Kreuter J. Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 1995;16:61-73
   Web of Science ®Google Scholar
• Kurpakus Wheater M, Kernacki KA, Hazlett LD. Corneal cell proteins and ocular surface pathology. Biotech Histochem 1999;74(3):146-59
   PubMed Web of Science ®Google Scholar
• Berry M, Ellingham RB, Corfield AP. Membrane-associated mucins in normal human conjunctiva. Invest Ophthalmol Vis Sci 2000;41:398-403
   PubMed Web of Science ®Google Scholar
• Round AN, Berry M, McMaster TJ, Heterogeneity and persistence length in human ocular mucins. Biophys J 2002;83(3):1661-70
   PubMed Web of Science ®Google Scholar
• Hazlett LD, Moon M, Berk RS. In vivo identification of sialic-acid as the ocular receptor for Pseudomonas-aeruginosa. Infect Immun 1986;51:687-9
   PubMed Web of Science ®Google Scholar
• Ellingham RB, Berry M, Stevenson D, Corfield AP. Secreted human conjunctival mucus contains MUC5AC glycoforms. Glycobiology 1999:9:1181-9
   PubMed Web of Science ®Google Scholar
• Le Bourlais C, Acar L, Zia H, Ophthalmic drug delivery systems recent advances. Prog Retin Eye Res 1998;17(1):33-58
   PubMed Web of Science ®Google Scholar
• Barbault-Foucher S, Gref R, Russo P, Design of poly--caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery. J Control Release 2002;83(3):365-75
   PubMed Web of Science ®Google Scholar
• Liesang TJ. Viscoelastic substances in ophthalmology. Surv Ophthalmol 1990;34(4):268-93
   PubMed Web of Science ®Google Scholar
• Saettone MF, Chetoni P, Torraca MT, Evaluation of mucoadhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid. Int J Pharm 1989;51:203-12
   Web of Science ®Google Scholar
• Marriott C, Gregory NP. Mucus physiology and pathology. In: Lenearts V, Gurny R, editors, Bioadhesive drug delivery systems. CRC Press, Boca Raton, Florida; 1990. p. 2-24
   Google Scholar
• Ludwig A, van Ooteghem M. Influence of viscoslysers on the residence of ophthalmic solutions evaluated by slip lamp fluorophotometry. STP Pharm Sci 1992;2(1):81-7
   Google Scholar
• Schoenwald RD, Ward R. Relationship between steroid permeability across excised rabbit cornea and octanol-water partition coefficients. J Pharm Sci 1978;67:786-8
   PubMed Web of Science ®Google Scholar
• Van Ooteghem M. Preparations ophtalmiques. In: Galenica, editor, Technique and documentation. Lavoisier, Paris; 1995
   Google Scholar
• Greaves JL, Olejnik O, Wilson CG. Polymers and the precorneal tear film. STP Pharm Sci 1992;2(1):13-33
   Google Scholar
• Dittgen M, Oestereich S, Eckhardt D. Influence of bioadhesion on the elimination of drugs from the eye and on their penetration ability across the pig cornea. STP Pharm Sci 1992;2(1):93-7
   Google Scholar
• Park H, Robinson JR. Mechanisms of mucoadhesion of poly(acrylic acid) and hydrogels. Pharm Res 1987;4(6):457-64
   PubMed Web of Science ®Google Scholar
• Ponchel G, Touchard F, Duchfine D, Peppas NA. Bioadhesive analysis of controlled-release systems. I. Fracture and interpenetration analysis in poly(acrylic acid)-containing systems. J Control Release 1987;5:129-41
   Google Scholar
• Duchfine D, Touchard F, Peppas NA. Pharmaceutical and medical aspects of bioadhesive systems of drug administration. Drug Dev Ind Pharm 1988;14(2-3):283-318
   Web of Science ®Google Scholar
• Slovin EM, Robinson JR. Bioadhesives in ocular drug delivery. In: Edman P, editor, Biopharmaceutics of ocular drug delivery. CRC Press, Boca Raton, Florida; 1993. p. 145-57
   Google Scholar
• Robinson JR. Ocular drug delivery mechanism(s) of corneal drug transport and mucoadhesive delivery systems. STP Pharm Sci 1989;5(12):839-46
   Google Scholar
• Park H, Robinson JR. Physico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion. J Control Release 1985;2:47-57
   Google Scholar
• Middleton DL, Leung SS, Robinson JR. Ocular bioadhesive delivery systems. In: Lenearts V, Gurny R, editors, Bioadhesive drug delivery systems. CRC Press, Boca Raton, Florida; 1990. p. 180-99
   Google Scholar
• Middleton DL, Robinson JR. Design and evaluation of an ocular bioadhesive delivery system. STP Pharm Sci 1991;1(3):200-6
   Google Scholar
• Motwani SK, Chopra S, Talegaonkar S, Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Eur J Pharm Biopharm 2008;68(3):513-25
   PubMed Web of Science ®Google Scholar
• Knapczyk J, Krowczynski L, Krzck J, Requirements of chitosan for pharmaceutical and biomedical applications. In: Skak-Braek G, Anthonsen T, Sandford P, editors, Chitin and chitosan: sources>, chemistry, biochemistry, physical properties and applications. Elsevier, London; 1989. p. 657-63
   Google Scholar
• Hirano S, Seino H, Akiyama I, Nonaka I. Chitosan: a biocompatible material for oral and intravenous administration. In: Gebelein CG, Dunn RL, editors, Progress in biomedical polymers. Plenum Press, New York; 1990. p. 283-9
   Google Scholar
• Takeuchi H, Yamamoto H, Niwa T, Enteral absorption of insulin in rats from mucoadhesive chitosancoated liposomes. Pharm Res 1996;13:896-901
   PubMed Web of Science ®Google Scholar
• Felt O, Furrer P, Mayer JM, Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of pre-corneal retention. Int J Pharm 1999;180:185-93
   PubMed Web of Science ®Google Scholar
• Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int J Pharm 1997;53:41-50
   Google Scholar
• Worakul N, Robinson JR. Ocular pharmacokinetics/ pharmacodynamics. Eur J Pharm Biopharm 1997;44(1627):71-83
   Google Scholar
• Araujo J, Vega E, Lopes C, Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B Biointerfaces 2009;72:48-56
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003;8:1112-20
   PubMed Web of Science ®Google Scholar
• Vasir JK, Reddy MK, Labhasetwar V. Nanosystems in drug targeting: opportunities and challenges. Curr Nanosci 2005;1:47-64
   Web of Science ®Google Scholar
• Sahoo SK, Dilnawaz F, Krishnakumar S. Nanotechnology in ocular drug delivery. Drug Discov Today 2008;13:144-50
   PubMed Web of Science ®Google Scholar
• Lemarchand C, Gref R, Couvreur P. Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm 2004;58(2):327-41
   PubMed Web of Science ®Google Scholar
• Lang JC. Ocular drug delivery conventional ocular formulations. Adv Drug Deliv Rev 1995;16:39-43
   Web of Science ®Google Scholar
• Meadows DL, Paugh JR, Joshi A, Mordaunt J. A novel method to evaluate residence time in humans using a nonpenetrating fluorescent tracer. Invest Ophthalmol Vis Sci 2002;43:1032-9
   PubMed Web of Science ®Google Scholar
• Barbu E, Verestiuc L, Nevell TG, Tsibouklis J. Polymeric materials for ophthalmic drug delivery: trends and perspectives. J Mater Chem 2006;16:3439-43
   Web of Science ®Google Scholar
• Nemoto E, Ueda H, Akimoto M, Ability of poly-Larginine to enhance drug absorption into aqueous humor and vitreous body after instillation in rabbits. Biol Pharm Bull 2007;30(9):1768-72
   PubMed Web of Science ®Google Scholar
• Ticho U, Blumenthal MD, Zonis S, A clinical trial with Piloplex – A new long-acting pilocarpine compound: preliminary report. Ann Ophthalmol 1979;11:555-61
   PubMed Web of Science ®Google Scholar
• Andermann G, de Burlet G, Cannet C. Comparative study of the antiglaucomatous activity of Glauplex 2 and pilocarpine nitrate on alpha-chymotrypsin-induced experimental glaucoma (article in French). J Fr Ophtalmol 1982;5(8-9):499-504
   PubMed Web of Science ®Google Scholar
• Wood RW, Li VHK, Kreuter J, Robinson JR. Ocular disposition of poly-hexyl-2-cyano(3-14C)acrylate nanoparticles in the albino rabbit. Int J Pharm 1985;23:175-83
   Web of Science ®Google Scholar
• Harmia T, Kreuter J, Speiser P, Enhancement of the myotic response of rabbits with pilocarpine-loaded polybutylcyanoacrylate nanoparticles. Int J Pharm 1986;33:187-93
   Web of Science ®Google Scholar
• Marchal-Heussler L, Orallo F, Vila-Jato JL, Alonso MJ. Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Pharm Res 1993;10(1):80-7
   PubMed Web of Science ®Google Scholar
• Das SK, Tucker IG, Hill DJT, Ganguly N. Evaluation of Poly(isobutylcyanoacrylate) nanoparticles for mucoadhesive ocular drug delivery. I. Effect of formulation variables on physicochemical characteristics of nanoparticles. Pharm Res 1995:12(4):534-40
   PubMed Web of Science ®Google Scholar
• Zimmer AK, Kreuter J, Robinson JR. Studies on the transport pathway of PBCA nanoparticles in ocular tissues. J Microencapsul 1991;8(4):497-504
   PubMed Web of Science ®Google Scholar
• Le Bourlais C, Chevarme F, Turlin B, Effect of cyclosporine A formulations on bovine corneal absorption: ex-vivo study. J Microencapsul 1997;14(4):457-67
   PubMed Web of Science ®Google Scholar
• Zimmer A, Mutschler E, Lambrecht G, Pharmacokinetic and pharmacodynamic aspects of an ophthalmic pilocarpine nanoparticle-delivery-system. Pharm Res 1994;11:1435-42
   PubMed Web of Science ®Google Scholar
• Zimmer AK, Chetoni P, Saettone MF, Evaluation of pilocarpine-loaded albumin particles as controlled drug delivery systems for the eye. II. Co-administration with bioadhesive and viscous polymers. J Control Release 1995;33:31-46
   Web of Science ®Google Scholar
• Alonso MJ, Calvo P, Vila-Jato JL, Increased ocular corneal uptake of drugs using poly-e-caprolactone nanocapsules and nanoemulsions, 22nd international Symposium Controlled Release Bioactive Materials 1995 (30th July – 4th August), Seattle, USA
   Google Scholar
• Peppas NA, Buri PA. Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J Control Release 1985;2:257-75
   Google Scholar
• Acheampong AA, Shackleton M, Tang-Liu DD, Distribution of cyclosporin A in ocular tissues after topical administration to albino rabbits and beagle dogs. Curr Eye Res 1999;18:91-103
   PubMed Web of Science ®Google Scholar
• Bellot JL, Alio JL, Moreno JMR, Artola A. Corneal concentration and systemic absorption of cyclosporin-A following its topical application in the rabbit eye. Ophthalmic Res 1992;24:351-6
   PubMed Web of Science ®Google Scholar
• Benitez del Castillo JM, Aghila C, Duran S, Influence of topically applied cyclosporin A in olive oil on corneal epithelium permeability. Cornea 1994;13:136-40
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB. The use of cyclosporine in ocular inflammatory disorders. Transplant Proc 1988;20:114-21
   PubMed Web of Science ®Google Scholar
• Dua HS, Jindal VK, Gomes JAP, The effect of topical cyclosporin on conjunctiva-associated lymphoid tissue (CALT). Eye 1996;10:433-438
   PubMed Web of Science ®Google Scholar
• Pignatello R, Bucolo C, Puglisi G. Ocular tolerability of Eudragit RS 100® and RL 100® nanosuspensions as carriers for ophthalmic controlled drug delivery. J Pharm Sci 2002;91:2636-41
   PubMed Web of Science ®Google Scholar
• Dillen K, Vandervoort J, Van den Mooter G, Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit® RS100 or RL100/PLGA nanoparticles. Int J Pharm 2006;314:72-82
   PubMed Web of Science ®Google Scholar
• Yerushalmi N, Arad A, Margalit R. Molecular and cellular studies of hyaluronic acid-modified liposomes as bioadhesive carriers for topical drug delivery in wound healing. Arch Biochem Biophys 1994;313:267-73
   PubMed Web of Science ®Google Scholar
• Sintzel MB, Bernatchez SF, Tabatabay C, Gurny R. Biomaterials in ophtalmic drug delivery. Eur J Pharm Biopharm 1996;42:358-74
   Web of Science ®Google Scholar
• Friess W. Collagen-material for drug delivery. Eur J Pharm Biopharm 1998;45:113-36
   PubMed Web of Science ®Google Scholar
• Van Doorne H. Interactions between cyclodextrins and ophthalmic drugs. Eur J Pharm Biopharm 1993;39:133-9
   Web of Science ®Google Scholar
• Stella VJ, Rajewski RA. Cyclodextrins: their future in drug formulation. Pharm Res 1997;14:556-67
   PubMed Web of Science ®Google Scholar
• Jarvinen T, Loftsson T. Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev 1999;36:59-79
   PubMed Web of Science ®Google Scholar
• Masson M, Loftsson T, Masson G, Stefansson E. Cyclodextrins as permeation enhancers: theoretical evaluations and in vitro testing. J Control Release 1999;59:107-18
   PubMed Web of Science ®Google Scholar
• Gref R, Minamitake Y, Peracchia MT, Biodegradable long-circulating polymeric nanospheres. Science 1994;263:1600-3
   PubMed Web of Science ®Google Scholar
• Bazile D, Prud'homme C, Bassoullet MT, Stealth MePEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J Pharm Sci 1995;84:493-8
   PubMed Web of Science ®Google Scholar
• Peracchia MT, Vauthier C, Desmaele D, Pegylated nanoparticles from a novel methoxypolyethylene glycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer. Pharm Res 1998;15:550-6
   PubMed Web of Science ®Google Scholar
• Stella B, Arpicco S, Peracchia MT, Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci 2000;89:1452-64
   PubMed Web of Science ®Google Scholar
• Listinsky JJ, Siegal GP, Listinsky CM. alpha- -Fucose, a potentially critical molecule in pathologic processes including neoplasia. Am J Clin Pathol 1998;110:425-40
   PubMed Web of Science ®Google Scholar
• Stahn R, Zeisig R. Cell adhesion inhibition by glycoliposomes: effects of vesicle diameter and ligand density. Tumor Biol 2000;21:176-86
   PubMed Web of Science ®Google Scholar
• Na K, Park K-H, Kim SW, Bae YH. Self-assembled hydrogel nanoparticles from curdlan derivatives: characterization, anti-cancer drug release and interaction with hepatoma cell line (HepG2). J Control Release 2000;69:225-36
   PubMed Web of Science ®Google Scholar
• Dumitriu S. Polysaccharides as biomaterials. In: Dumitriu S, editor, Polymeric biomaterials, Marcel Dekker, New York; 2001. p. 1-61
   Google Scholar
• Yuan X, Li H, Yuan Y. Preparation of cholesterol-modified chitosan self-aggregated nanoparticles for delivery of drugs to ocular surface. Carbohydr Polym 2006;65(3):337-45
   Web of Science ®Google Scholar
• Ohya Y, Cai R, Nishizawa H, Preparation of PEG-grafted chitosan nano-particle for peptide drug carrier. Proc Int Symp Control Release Bioact Mat 1999;26:655-6
   Google Scholar
• Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1998;172:33-70
   Web of Science ®Google Scholar
• Lee KY, Kwon IC, Kim YH, Preparation of chitosan self-aggregates as a gene delivery system. J Control Release 1998;51:213-20
   PubMed Web of Science ®Google Scholar
• Yuan X, Yuan Y, Jiang W, Preparation of rapamycin-loaded chitosan/PLA nanoparticles for immunosuppression in corneal transplantation. Int J Pharm 2008;349:241-8
   PubMed Web of Science ®Google Scholar
• Gottenbos B, Grijpma DW, van der Mei HC, Antimicrobial effects of positively charged surfaces on adhering Gram-positive and Gram-negative bacteria. J Antimicrob Chemother 2001;48:7-13
   PubMed Web of Science ®Google Scholar
• Dunne WM. Bacterial adhesion: seen any good biofilms lately? Clin Microbiol Rev 2002;15:155-66
   PubMed Web of Science ®Google Scholar
• Gottenbos B, van der Mei HC, Klatter F, Positively charged biomaterials exert antimicrobial effects on gram-negative bacilli in rats. Biomaterials 2003;24:2707-10
   PubMed Web of Science ®Google Scholar
• Dillen K, Vandervoort J, Van den Mooter G, Ludwig A. Evaluation of ciprofloxacin-loaded Eudragit® RS100 or RL100/PLGA nanoparticles. Int J Pharm 2006;314:72-82
   PubMed Web of Science ®Google Scholar
• Moreau JM, Conerly LL, Hume EBH, Effectiveness of mupirocin and polymyxin B in experimental Staphylococcus aureus, Pseudomonas aeruginosa, and Serratia marcescens keratitis. Cornea 2002;21:807-11
   PubMed Web of Science ®Google Scholar
• Gan L, Han S, Shen J, Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm 2010;396:179-87
   PubMed Web of Science ®Google Scholar
• De S, Robinson D. Polymer relationships during preparation of chitosan–alginate and poly-L-lysine–alginate nanospheres. J Control Release 2003;89:101-12
   PubMed Web of Science ®Google Scholar
• Yan XL, Khor E, Lim LY. Chitosan-alginate films prepared with chitosans of different molecular weights. J Biomed Mater Res 2001;58:358-65
   PubMed Web of Science ®Google Scholar
• Shell JW. Ophthalmic drug delivery systems. Drug Dev Res 1985;6:245-61
   Web of Science ®Google Scholar
• Carafa M, Santucci E, Alhaique F, Preparation and properties of new unilamellar non-ionic surfactant vesicles. Int J Pharm 1998;160:51-9
   Web of Science ®Google Scholar
• Kaur IP, Aggarwal D, Singh H, Kakkar S. Improved ocular absorption kinetics of timolol maleate loaded into a bioadhesive niosomal delivery system. Graefes Arch Clin Exp Ophthalmol 2010;248(10):1467-72
   PubMed Web of Science ®Google Scholar
• Lee VHL, Takemoto KA, Iimoto DS. Precorneal factors influencing the ocular distribution of topically applied liposomal inulin. Curr Eye Res 1984;3:585-91
   PubMed Web of Science ®Google Scholar
• Smolin G, Okumoto M, Feiler S, Condon D. Idoxuridine-liposome therapy for herpes simplex keratitis. Am J Ophthalmol 1981;91:220-5
   PubMed Web of Science ®Google Scholar
• Megaw JM, Takei Y, Lerman S. Lectinmedicated binding of liposomes to the ocular lens. Exp Eye Res 1981;32:395-405
   PubMed Web of Science ®Google Scholar
• Megaw J. Delivery of liposome-encapsulated drugs to the ocular lens. Lens Res 1983;1:221-34
   Google Scholar
• Schaeffer HE, Krohn DL. Liposomes in topical drug delivery. Invest Ophthalmol Vis Sci 1982;22:220-7
   PubMed Web of Science ®Google Scholar
• Singh K, Mezei M. Liposomal ophthalmic drug delivery. II. Dihydrostreptomycin sulphate. Int J Pharm 1984;19:263-9
   Google Scholar
• Fitzgerald P. Ph.D. Thesis. Ophthalmic Drug Delivery Systems. University of Nottingham, Nottingham, UK; 1985
   Google Scholar
• Davies NM, Farr SJ, Hadgraft J, Kellaway IW. Evaluation of mucoadhesive polymers in ocular drug delivery. II. Polymer-coated vesicles. Pharm Res 1992;9(9):1137-44
   PubMed Web of Science ®Google Scholar
• Fitzgerald P, Hadgraft J, Wilson CG. A gamma scintigraphic evaluation of the precorneal residence of liposomal formulations in the rabbit. J Pharm Pharmacol 1987;39:487-90
   PubMed Web of Science ®Google Scholar
• Szulc J, Woyczikowski B, De Laval W. Effect of pilocarpine hydrochloride liposomes on the intraocular pressure of the rabbit eye pupil. Farm Pol 1988;44:462-5
   Google Scholar
• Taniguchi K, Yamamoto Y, Itakura K, Assessment of ocular irritability of liposome preparations. J Pharmacobiodyn 1988;11:607-11
   PubMedGoogle Scholar
• Taniguchi K, Itakura K, Yamazawa N, Efficacy of a liposome preparation of antiinflammatory steroid as an ocular drug-delivery system. J Pharmacobiodyn 1988;11:39-46
   PubMedGoogle Scholar
• Norley SG, Sendele D, Huang L, Rouse BT. Inhibition of herpes simplex virus replication in the mouse cornea by drug containing immunoliposomes. Invest Ophthalmol Vis Sci 1987;28:591-5
   PubMed Web of Science ®Google Scholar
• Guo LSS, Sarris AM, Levy MD. A safe bioadhesive liposomal formulation for ophthalmic applications. Invest Ophthalmol Vis Sci 1989;29(Suppl):439
   Google Scholar
• McCalden TA, Levy M. Retention of topical liposomal formulations on the cornea. Experientia 1990;46:713-15
   PubMedGoogle Scholar
• Durrani AM, Davies NM, Thomas M, Kellaway IW. Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system. Int J Pharm 1992;88:409-15
   Web of Science ®Google Scholar
• Milani JK, Pleyer U, Dukes A, Prolongation of corneal allograft survival with liposome-encapsulated cyclosporine in the rat eye. Ophthalmology 1993;100(6):890-6
   PubMed Web of Science ®Google Scholar
• Pleyer U, Elkins B, Riickert D, Ocular absorption of cyclosporine A from liposomes incorporated into collagen shields. Curr Eye Res 1994;13:177-81
   PubMed Web of Science ®Google Scholar
• Bochot A, Fattal E, Gulik A, Liposomes dispersed within a thermosensitive gel: a new dosage form for ocular delivery of oligonucleotides. Pharm Res 1998;15(9):1364-9
   PubMed Web of Science ®Google Scholar
• Kubota N, Tatsumoto N, Sano T, Toya K. A simple preparation of half N-acetylated chitosan highly soluble in water and aqueous organic solvents. Carbohydr Res 2000;324:268-74
   PubMed Web of Science ®Google Scholar
• Diestelhorst M, Schmidl B, Konen W, Efficacy and tolerance of diclofenac sodium 0.1%, flurbiprofen 0.03%, and indomethacin 1.0% in controlling postoperative inflammation. J Cataract Refract Surg 1996;22(Suppl 1):788-93
   PubMedGoogle Scholar
• Kaur IP, Garg A, Aggarwal D. Vesicular systems in ocular drug delivery: an overview. Int J Pharm 2004;269:1-14
   PubMed Web of Science ®Google Scholar
• Maestrelli F, Garcia-Fuentes M, Mura P, Alonso MJ. A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin. Eur J Pharm Biopharm 2006;63:79-86
   PubMed Web of Science ®Google Scholar
• Sonvico F, Cagnani A, Rossi A, Formation of self-organized nanoparticles by lecithin/ chitosan ionic interaction. Int J Pharm 2006;324:67-73
   PubMed Web of Science ®Google Scholar
• Stella VJ, Rajewski RA. Cyclodextrins: their future in drug formulation and delivery. Pharm Res 1997;14:556-67
   PubMed Web of Science ®Google Scholar
• Del Valle EMM. Cyclodextrins and their uses: a review. Proc Biochem 2004;39:1033-46
   Web of Science ®Google Scholar
• Teijeiro-Osorio D, Remunan-Lopez C, Alonso MJ. New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules. Biomacromolecules 2008;10:243-9
   Web of Science ®Google Scholar
• Teijeiro-Osorio D, Remunan-Lopez C, Alonso MJ. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro. Eur J Pharm Biopharm 2008;71:257-63
   PubMed Web of Science ®Google Scholar
• Hauswirth WW, Beaufrere L. Ocular gene therapy: Quo vadis? Invest Ophthalmol Vis Sci 2000;41:2821-6
   PubMed Web of Science ®Google Scholar
• Borras T. Recent developments in ocular gene therapy. Exp Eye Res 2003;76:643-52
   PubMed Web of Science ®Google Scholar
• Pleyer U, Ritter T. Gene therapy in immune-mediated diseases of the eye. Prog Retin Eye Res 2003;22:277-93
   PubMed Web of Science ®Google Scholar
• Reich SJ, Bennett J. Gene therapy for ocular neovascularization: a cure in sight. Curr Opin Genet Dev 2003;13:317-22
   PubMed Web of Science ®Google Scholar
• Fattal E, Bochot A. Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. Adv Drug Deliv Rev 2006;58:1203-23
   PubMed Web of Science ®Google Scholar
• Toropainen E, Hornof M, Kaarniranta K, Corneal epithelium as a platform for secretion of transgene products after transfection with liposomal gene eyedrops. J Gene Med 2007;9:208-16
   PubMed Web of Science ®Google Scholar
• Mainardes RM, Urban MC, Cinto PO, Colloidal carriers for ophthalmic drug delivery. Curr Drug Targets 2005;6:363-71
   PubMed Web of Science ®Google Scholar
• Ghate D, Edelhauser HF. Ocular drug delivery. Expert Opin Drug Deliv 2006;3:275-87
   PubMed Web of Science ®Google Scholar
• del Amo EM, Urtti A. Current and future ophthalmic drug delivery systems. A shift to the posterior segment. Drug Discov Today 2008;13:135-43
   PubMed Web of Science ®Google Scholar
• Gaudana R, Jwala J, Boddu SHS, Mitra AK. Recent perspectives in ocular drug delivery. Pharm Res 2009;26:1197-16
   PubMed Web of Science ®Google Scholar
• Carr MG, Corish J, Corrigan OI. Drug delivery from a liquid crystalline base across Visking and human stratum corneum. Int J Pharm 1997;157:35-42
   Web of Science ®Google Scholar
• Lee J, Kellaway IW. Buccal permeation of [d-Ala(2), d-Leu(5)] enkephalin from liquid crystalline phases of glycerylmonooleate. Int J Pharm 2000;195:35-8
   PubMed Web of Science ®Google Scholar
• Lee J, Kellaway IW. Combined effect of oleic acid and polyethyleneglycol 200 on buccal permeation of [d-Ala(2), d-Leu(5)] enkephalin from a cubic phase of glycerylmonooleate. Int J Pharm 2000;204:137-44
   PubMed Web of Science ®Google Scholar
• Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Adv Drug Deliv Rev 2001;47:229-50
   PubMed Web of Science ®Google Scholar
• Nakano M, Teshigawara T, Sugita A, Dispersions of liquid crystalline phases of the monoolein/oleic acid/PluronicF127 system. Langmuir 2002;18:9283-8
   Web of Science ®Google Scholar
• Siekmann B, Bunjes H, Koch MH, Westesen K. Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phases. Int J Pharm 2002;244:33-43
   PubMed Web of Science ®Google Scholar
• Boyd BJ. Characterisation of drug release from cubosomes using the pressure ultrafiltration method. Int J Pharm 2003;260:239-47
   PubMed Web of Science ®Google Scholar
• Lopes LB, Ferreira DA, dePaula D, Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporine A. Pharm Res 2006;23:1332-42
   PubMed Web of Science ®Google Scholar
• Lee S-B, Geroski DH, Prausnitz MR, Edelhauser HF. Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems. Exp Eye Res 2004;78:599-607
   PubMed Web of Science ®Google Scholar
• Leesajakul W, Nakano M, Taniguchi A, Handa T. Interaction of cubosomes with plasma components resulting in the destabilization of cubosomes in plasma. Colloid Surf 2004;34:253-8
   PubMed Web of Science ®Google Scholar
• Esposito E, Cortesi R, Drechsler M, Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharm Res 2005;22:2163-73
   PubMed Web of Science ®Google Scholar
• Kim J, Chauhan A. Dexamethasone transport and ocular delivery from poly(hydroxyethyl methacrylate) gels. Int J Pharm 2008;353:205-22
   PubMed Web of Science ®Google Scholar
• Kompella UB, Sundaram S, Raghava S, Escobar ER. Luteinizing hormone-releasing hormone agonist and transferrin functionalizations enhance nanoparticle delivery in a novel bovine ex vivo eye model. Mol Vision 2006;12:1185-98
   PubMed Web of Science ®Google Scholar
• Grehn F, Stamper R. Essentials in ophthalmology: Glaucoma. Springer, Heidelberg, Germany; 2006. p. 52
   Google Scholar
• Svenson S, Tomalia D. Dendrimers in biomedical applications – reflections on the field. Adv Drug Deliv Rev 2005;57:2106-29
   PubMed Web of Science ®Google Scholar
• Chang JN. Recent advances in ophthalmic drug delivery. Handbook of non-invasive drug delivery systems. Elsevier, Amsterdam; 2009. p. 165-92
   Google Scholar
• Durairaj C, Kadam RS, Chandler JW, Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin. Invest Ophthalmol Vis Sci 2010;51(11):5804-16
   PubMed Web of Science ®Google Scholar
• Diebold Y, Calonge M. Applications of nanoparticles in ophthalmology. Prog Retin Eye Res 2010; In press
   Google Scholar
• Uchio E, Ohno S, Kudoh J, Simulation model of an eyeball based on finite element analysis on a supercomputer. Br J Ophthalmol 1999;83:1106-11
   PubMed Web of Science ®Google Scholar
• Fu J, Feng X, Yuan H, Study of ocular pharmacokinetics of in situ gel system for S(−)-satropane evaluated by microdialysis. J Pharm Biomed Anal 2008;48:840-3
   PubMed Web of Science ®Google Scholar
• Johnson KT, Fath KR, Henricus MM, Banerjee IA. Self-assembly and growth of smart cell-adhesive mucin-bound microtubes. Soft Materials 2009;7(1):21-36
   Web of Science ®Google Scholar